Home > Cashflow Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Cashflow Statement

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹29 Cr₹2.02 Cr₹57 Cr₹55 Cr₹44 Cr
Adjustment ₹7.43 Cr₹-1.14 Cr₹8.03 Cr₹1.18 Cr₹-0.59 Cr
Changes In working Capital ₹-68 Cr₹11 Cr₹-47 Cr₹-16 Cr₹-41 Cr
Cash Flow after changes in Working Capital ₹-32 Cr₹12 Cr₹18 Cr₹40 Cr₹2.60 Cr
Cash Flow from Operating Activities ₹-35 Cr₹4.87 Cr₹6.08 Cr₹34 Cr₹0.00 Cr
Cash Flow from Investing Activities ₹-22 Cr₹-1.05 Cr₹-11 Cr₹-28 Cr₹-5.97 Cr
Cash Flow from Financing Activities ₹34 Cr₹30 Cr₹26 Cr₹-0.16 Cr₹3.65 Cr
Net Cash Inflow / Outflow ₹-23 Cr₹34 Cr₹21 Cr₹5.53 Cr₹-2.32 Cr
Opening Cash & Cash Equivalents ₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹39 Cr₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr

Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹120.6 Cr -4.9% -15.5% -68.4% Stock Analytics
ADANI ENTERPRISES ₹276,809.0 Cr -4.8% -0.6% -2.5% Stock Analytics
REDINGTON ₹20,568.5 Cr -3.2% -3.8% 14.4% Stock Analytics
HONASA CONSUMER ₹9,809.9 Cr 2.6% 4.7% 39.6% Stock Analytics
MMTC ₹9,583.5 Cr -3.3% -11% -1.8% Stock Analytics
LLOYDS ENTERPRISES ₹8,443.4 Cr -5.6% -6.6% 22.4% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-4.9%

-15.5%

-68.4%

SENSEX

-1.1%

-1.2%

5.9%


You may also like the below Video Courses